Sponsor or institution
Clinical trials and research at Kiniksa Pharmaceuticals International, plc
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Kiniksa Pharmaceuticals International, plc that are recruiting, at sites in 10 countries (most in Canada (2), France (2), Germany (2)). By phase: Phase 2 (1), Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 10Countries
All recruiting trials (2)
-
Transitioning people with recurrent pericarditis to KPL-387 monotherapy dosing and administration
This trial will try switching people with well-controlled recurrent pericarditis from their current therapies to KPL-387 alone for up to 16 weeks to see if symptoms and inflammation stay controlled and the drug is tolerable.
-
KPL-387 for recurrent pericarditis
This trial tests whether KPL-387 can control pain and inflammation and lower the chance of future attacks in people having an acute episode of recurrent pericarditis despite standard treatment.
Quick answers
How many clinical trials run by Kiniksa Pharmaceuticals International, plc are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 10 countries. The most sites are in Canada (2 trials), France (2 trials), Germany (2 trials), Greece (2 trials), Italy (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.